260 related articles for article (PubMed ID: 8349072)
41. Increased levels of soluble complement receptor 1 in serum patients with liver diseases.
Sadallah S; Giostra E; Mentha G; Schifferli JA
Hepatology; 1996 Jul; 24(1):118-22. PubMed ID: 8707249
[TBL] [Abstract][Full Text] [Related]
42. Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.
Myers RP; Ratziu V; Imbert-Bismut F; Charlotte F; Poynard T;
Am J Gastroenterol; 2002 Sep; 97(9):2419-25. PubMed ID: 12358267
[TBL] [Abstract][Full Text] [Related]
43. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
[TBL] [Abstract][Full Text] [Related]
44. Hepatic iron stainings in chronic hepatitis C patients with low HCV RNA levels: a predictive marker for IFN therapy.
Akiyoshi F; Sata M; Uchimura Y; Suzuki H; Tanikawa K
Am J Gastroenterol; 1997 Sep; 92(9):1463-6. PubMed ID: 9317063
[TBL] [Abstract][Full Text] [Related]
45. Serum transforming growth factor-beta1(TGF-beta1) in patients with cirrhosis, chronic hepatitis B and chronic hepatitis C [corrected].
Kirmaz C; Terzioglu E; Topalak O; Bayrak P; Yilmaz O; Ersoz G; Sebik F
Eur Cytokine Netw; 2004; 15(2):112-6. PubMed ID: 15319169
[TBL] [Abstract][Full Text] [Related]
46. [Clinical significance of haptoglobin in chronic hepatitis and liver cirrhosis of viral etiology].
Denisenko LN
Ter Arkh; 1971 Oct; 43(10):38-41. PubMed ID: 5140948
[No Abstract] [Full Text] [Related]
47. Serum haptoglobin concentrations in acute hepatitis A.
Iwashita T
Southeast Asian J Trop Med Public Health; 1986 Jun; 17(2):197-200. PubMed ID: 3787307
[TBL] [Abstract][Full Text] [Related]
48. [Decrease of cholesterolemia and apolipoprotein B in chronic viral hepatitis C with massive steatosis].
Carré D; Boucher E; Turlin B; Guyader D; Brissot P; Deugnier Y
Gastroenterol Clin Biol; 1994; 18(10):899-900. PubMed ID: 7875402
[No Abstract] [Full Text] [Related]
49. [Changes in the serum protein picture in viral hepatitis. II. Evaluation of the proteins in the acute phase].
Borsotti M; De Philippis C; Leoncini F; Mazzotta F; Paci F; Piazza E; Spadolini MP
Quad Sclavo Diagn; 1980 Dec; 16(4):385-401. PubMed ID: 6166020
[TBL] [Abstract][Full Text] [Related]
50. [Serum haptoglobin and 5'-nucleotidase levels in patients with acute viral hepatitis with low and high bilirubin levels].
Fijałka-Rymar M; Radomińska I; Gdula-Malec R
Wiad Lek; 1982 Aug; 35(13):765-9. PubMed ID: 6293205
[No Abstract] [Full Text] [Related]
51. [Serum haptoglobin levels in healthy and diseased individuals].
Morita K; Mizuochi K; Sato S
Nihon Hoigaku Zasshi; 1984 Apr; 38(2):177-82. PubMed ID: 6482071
[No Abstract] [Full Text] [Related]
52. [Serum haptoglobin level, 5'-nucleotidase activity and the presence of HBs in patients with acute viral hepatitis].
Malec R; Modrzewska R; Pomorska M
Wiad Lek; 1983 May; 36(10):805-9. PubMed ID: 6312699
[No Abstract] [Full Text] [Related]
53. Dapsone induced hypohaptoglobinemia in lepromatous leprosy patients.
Sritharan V; Bharadwaj VP; Venkatesan K; Girdhar BK
Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):307-10. PubMed ID: 7198620
[TBL] [Abstract][Full Text] [Related]
54. Serum selenium concentration in liver cirrhotic patients suffering from hepatitis B and C in Pakistan.
Rauf N; Tahir SS; Dilawar S; Ahmad I; Parvez S
Biol Trace Elem Res; 2012 Feb; 145(2):144-50. PubMed ID: 21898107
[TBL] [Abstract][Full Text] [Related]
55. Plasma fibronectin and serum complement C3 levels in chronic active hepatitis following virus "B" versus virus "C" infection.
Abdel Rahman MM; el Nasr MS; Mahmoud SA; Soliman A; Salama MM
J Egypt Soc Parasitol; 1993 Aug; 23(2):579-89. PubMed ID: 8376876
[TBL] [Abstract][Full Text] [Related]
56. Functional activity of protein C in liver cirrhosis and acute viral hepatitis on the Ivory Coast.
Blavy G; Nasreddine ML; Kouassi D
Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):339-40. PubMed ID: 7971257
[TBL] [Abstract][Full Text] [Related]
57. [Correction of haptoglobin contents in hemolytic specimen with addition of saturated hemoglobin].
Okazaki T; Arakawa H
Rinsho Byori; 1992 May; 40(5):557-62. PubMed ID: 1507484
[TBL] [Abstract][Full Text] [Related]
58. Sulphur amino acid pattern in chronic liver disease.
Almasio P; Bianchi G; Marchesini G; Luca A; Bugianesi E; Le Grazie C; Pagliaro L
Ital J Gastroenterol; 1994; 26(1):21-5. PubMed ID: 8025302
[TBL] [Abstract][Full Text] [Related]
59. [Porphyrin biosynthesis in patients with acute viral hepatitis, chronic hepatitis and liver cirrhosis].
Pisanets MP; Alagezian DS
Klin Med (Mosk); 1987 Sep; 65(9):76-8. PubMed ID: 3695317
[No Abstract] [Full Text] [Related]
60. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis.
Kawasaki T; Takeshita A; Souda K; Kobayashi Y; Kikuyama M; Suzuki F; Kageyama F; Sasada Y; Shimizu E; Murohisa G; Koide S; Yoshimi T; Nakamura H; Ohno R
Am J Gastroenterol; 1999 Jul; 94(7):1918-22. PubMed ID: 10406260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
